Literature DB >> 17944768

Referral pathways and diagnosis: UK government actions fail to recognize complexity of lymphoma.

D A Howell1, A G Smith, E Roman.   

Abstract

To gain survival advantages potentially associated with prompt diagnosis, the UK government introduced identical waiting-time targets for all cancers, and guidelines to ensure that general practitioners make appropriate hospital referrals. For lymphoma, the evidence guiding these actions is limited. This study examined referral pathways in patients with lymphoma and variations in time to diagnosis by discipline of first referral. A case series study was conducted including all patients aged over 25 years, newly diagnosed with lymphoma in the UK county of West Yorkshire, during 2000. Data were extracted from primary care and hospital records of 189 patients. Referral pathways were described, and the number of days between first referral and diagnosis calculated. A distinct referral pathway did not exist; patients were initially referred to many disciplines. Surgical referrals predominated, and only 12% of patients were sent directly to haematology. Time to diagnosis varied by discipline and was shorter for patients sent to haematology than for most other common disciplines. UK government actions to ensure the prompt diagnosis of patients with lymphoma are not evidence-based. The complexity of the referral pathway in patients with lymphoma, which affects time to diagnosis, has been underestimated. Further government actions should be evidence-based, ensuring prompt diagnosis of lymphoma from whatever discipline patients originate.

Entities:  

Mesh:

Year:  2007        PMID: 17944768     DOI: 10.1111/j.1365-2354.2007.00789.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  6 in total

1.  Quantifying the risk of non-Hodgkin lymphoma in symptomatic primary care patients aged ≥40 years: a large case-control study using electronic records.

Authors:  Elizabeth A Shephard; Richard D Neal; Peter W Rose; Fiona M Walter; William T Hamilton
Journal:  Br J Gen Pract       Date:  2015-05       Impact factor: 5.386

2.  Waiting time to lymph node biopsy is dependent on referral method: don't write, phone!

Authors:  S A J Pannick; C L Ingham Clark
Journal:  Ann R Coll Surg Engl       Date:  2009-09-25       Impact factor: 1.891

3.  Evaluation of unexplained peripheral lymphadenopathy and suspected malignancy using a distinct quick diagnostic delivery model: prospective study of 372 patients.

Authors:  Xavier Bosch; Emmanuel Coloma; Carolina Donate; Lluís Colomo; Pamela Doti; Anna Jordán; Alfonso López-Soto
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

4.  Time to diagnosis and associated costs of an outpatient vs inpatient setting in the diagnosis of lymphoma: a retrospective study of a large cohort of major lymphoma subtypes in Spain.

Authors:  Xavier Bosch; Carmen Sanclemente-Ansó; Ona Escoda; Esther Monclús; Jonathan Franco-Vanegas; Pedro Moreno; Mar Guerra-García; Neus Guasch; Alfons López-Soto
Journal:  BMC Cancer       Date:  2018-03-12       Impact factor: 4.430

5.  Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological Malignancy Research Network.

Authors:  Debra A Howell; Alexandra G Smith; Andrew Jack; Russell Patmore; Una Macleod; Emma Mironska; Eve Roman
Journal:  BMC Hematol       Date:  2013-10-31

6.  Risk factors and time to symptomatic presentation in leukaemia, lymphoma and myeloma.

Authors:  Debra A Howell; Fiona Warburton; Amanda-Jane Ramirez; Eve Roman; Alexandra G Smith; Lindsay J L Forbes
Journal:  Br J Cancer       Date:  2015-09-01       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.